ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 652565 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 652565; 2) Community: the network communities that were significantly associated with the response to NSC 652565; 3) Molecule: the relationships between components within communities and NSC 652565; 4) MDR: the compounds that were significantly associated with the NSC 652565.

NSC Compound Enrichment Correlation
NSC 691778 Null 0.012374497233828 0.2625835
NSC 713320 Null 0.012374497233828 0.40966521
NSC 737342 6-(3-Azidopropyl)-5,6-dihydro-2,3,9-trimethoxy-5,11-dioxo-11 H-indeno[1,2-c]isoquinoline 0.012374497233828 0.41218871
NSC 740645 Indenoisoquinoline derivative 0.012374497233828 0.54872873
NSC 743434 8-(4-{5-[3-(4-fluoro phenyl)-3-oxo-1-prophenyl]-2-methoxy phenoxy}pentoxy)-7-methoxy-2,3,5,11-a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a],[1,4]diazepin-5-one 0.012374497233828 0.38587606
NSC 748904 [(20S)-20-(N,N-dimethylamino)-5a-preg-3a-aminal], N-formylchonemorphine 0.012374497233828 0.25060716
NSC 749908 Ferric-taxol 0.012374497233828 -0.0073515308
NSC 752464 methyl 2-((S,3Z)-6-((E)-1-hydroxy-3-phenylallylidene)-5-oxocyclohex-3-enyl)acetate 0.012374497233828 0.3397764
NSC 112758 Rubomycin 0.0123744972338281 0.30811684
NSC 127328 Guanidine, 1-(4-chloro-.alpha.,.alpha.,.alpha.-trifluoro-m-tolyl)-3-[4-[[2-(diisopropylamino)ethyl]amino]-6-methyl-2-pyrimidinyl]- 0.0123744972338281 0.11552364
Total:73  Current:20    [First] [Prev] [Next] [Last]